J&J | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
AbbVie USD 1.66B 3.15B 2025-03
Abbott USD 2.15B 372M 2025-06
Amgen USD 1.57B 405M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Baxter International USD -3000000 286M 2025-03
Bayer EUR -426000000 2.26B 2025-06
Becton, Dickinson and Co. USD 703M 340M 2025-06
Biogen USD 744M 432.8M 2025-06
Boston Scientific USD 941M 302M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
CONMED USD 29.92M 22.25M 2025-06
Cooper Companies USD 151.9M 7.4M 2025-07
Dexcom USD 241.1M 86.8M 2025-06
Edwards Lifesciences USD 400.2M 33.7M 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
GlaxoSmithKline GBP 1.89B 221M 2025-06
Globus Medical USD 188.17M 84.5M 2025-06
Hologic USD 235M 263.5M 2025-06
Insulet USD 28.4M 19.7M 2025-06
Integra LifeSciences USD -530952000 500.92M 2025-06
Intuitive Surgical USD 832.1M 163.6M 2025-06
J&J USD 13.63B 8.21B 2025-03
Medtronic USD 1.87B 612M 2025-07
Merck USD 6.77B 864M 2025-06
Merit Medical Systems USD 43.38M 5.42M 2025-06
Novartis USD 4.53B 124M 2025-06
Pfizer USD 3.04B 259M 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
Stryker USD 1.02B 252M 2025-06
Tandem Diabetes Care USD -57722000 64.37M 2025-06
Teva Pharmaceutical Industries USD 203M 91M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06
Zimmer Biomet Holdings USD 224.6M 4.4M 2025-06
Zoetis USD 902M 92M 2025-06


J&J Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.